TFF Pharmaceuticals’ Kayla Hannon and University of Sheffield’s Dr. Zoltán Kis discuss the cost and capacity implications of therapeutic demand surges in this segment of the Bioprocess Online Live event, Surge Manufacturing for Biopharma Resilience.
View the full presentation here.
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Please enter your email address and create a password to access the full content, Or
log in to your account to continue.
Please tell us more about you so that we can customize our newsletters to your specific interests: